Research News and Research

RSS

NeoGenomics validates and launches series of NeoTYPE cancer profiling tests

NeoGenomics, Inc., a leading provider of cancer-focused genetic and molecular testing services, announced today that it has validated and launched a series of NeoTYPE cancer profiling tests covering 22 different categories of cancer. Each of these tests is designed to investigate the most common and actionable genomic abnormalities reported for that particular tumor.

30 Jan 2014

First Edition: January 30, 2014

Today's headlines include stories about a new poll examining how uninsured people -- one of the groups the health law was designed to help -- view the overhaul.

30 Jan 2014

Not all children, young adults treated achieve long-term relief from symptoms of anxiety

Fewer than one in two children and young adults treated for anxiety achieve long-term relief from symptoms, according to the findings of a study by investigators from the Johns Hopkins Children's Center and five other institutions.

30 Jan 2014

Alexion Pharmaceuticals reports full year 2013 GAAP and non-GAAP financial results

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2013. For the three months ended December 31, 2013, Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") reported net product sales of Soliris® (eculizumab) of $441.9 million, compared to $320.5 million for the same period in 2012.

30 Jan 2014

Thermo Fisher Scientific fourth quarter revenue increases 6% to $3.47 billion

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2013.

30 Jan 2014

Neuroscientist, researchers receive Vilcek Prize in Biomedical Science

The Vilcek Foundation is pleased to name Thomas M. Jessell as the winner of the 2014 Vilcek Prize in Biomedical Science. Awarded annually, the Vilcek Prizes honor the contributions of immigrants to the American arts and sciences, and include $100,000 cash awards.

30 Jan 2014

American Cancer Society, SU2C partner to fight against cancer

The American Cancer Society, the largest voluntary health organization in the world dedicated to eliminating cancer, and Stand Up To Cancer, the charitable initiative supporting groundbreaking research aimed at getting new treatments to patients in an accelerated timeframe, announced today an historic collaboration in the fight against cancer, which takes more than 585,000 lives in the U.S. each year and nearly 8 million worldwide.

30 Jan 2014

New molecule could help lower diabetic patients' risk of developing dementia or Alzheimer's

Researchers at the Hebrew university of Jerusalem have created a molecule that could potentially lower diabetic patients' higher risk of developing dementia or Alzheimer's disease.

30 Jan 2014

Geranium plant extracts prevent HIV-1 from invading human cells

Extracts of the geranium plant Pelargonium sidoides inactivate human immunodeficiency virus type 1 (HIV-1) and prevent the virus from invading human cells. In the current issue of "PLOS ONE", scientists from the Helmholtz Zentrum München report that these extracts represent a potential new class of anti-HIV-1 agents for the treatment of AIDS.

30 Jan 2014

UCLH selects Nexthink's V5 modular platform to improve IT infrastructure

Nexthink, the unique provider of End-user IT Analytics, has today announced that its V5 modular platform has been selected by University College London Hospitals NHS Foundation Trust to provide real-time visibility and analytics across its technical estate and network infrastructure.

30 Jan 2014

CTI announces initiation of pacritinib Phase 2 trial in AML patients with FLT3 mutations

Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.

30 Jan 2014

Heart transplantation continues to be "gold standard" treatment for end-stage heart failure

Heart transplantation continues to be the "gold standard" treatment for end-stage heart failure, and a large number of patients now live 20 years or more after surgery, according to a study in the February 2014 issue of The Annals of Thoracic Surgery.

30 Jan 2014

Researchers engineer skin cells for first time containing blood and lymphatic capillaries

Researchers at the University Children's Hospital Zurich and the University of Zurich have engineered skin cells for the very first time containing blood and lymphatic capillaries. They succeeded in isolating all the necessary types of skin cells from human skin tissue and engineering a skin graft that is similar to full-thickness skin.

30 Jan 2014

New pre-clinical data shows potential protective effects of GFT505 in different types of cancer

GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.

30 Jan 2014

Singapore to become a major hub in Asia for food and nutrition research

The Clinical Nutrition Research Centre - a $20 million joint-venture by the Agency for Science, Technology and Research and National University Health Systems - is the most comprehensive centre in Asia that will conduct nutritional studies to understand the causes of metabolic diseases such as diabetes and obesity, and develop products and formulate diets that can reduce the risks of these diseases. CNRC will also conduct studies in research areas such as nutrition in women, children and the elderly, and body weight control.

30 Jan 2014

Researcher to study how to address shortage of mental health services in Vietnam

A Simon Fraser University researcher is going to Vietnam to study how to address the shortage of accessible and adequate services for people with mental disorders like depression and anxiety.

30 Jan 2014

Findings could improve clinical management of patients with breast tissue abnormalities

Contrary to existing understanding, long-term follow-up of patients with two types of breast tissue abnormalities suggests that both types of abnormalities have the same potential to progress to breast cancer, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research. Findings from this study could improve clinical management of patients with breast tissue abnormalities.

30 Jan 2014

Postdoctoral Fellowship Program for excellent early-career scientists at Helmholtz Zentrum München

The Postdoctoral Fellowship Program is a newly established program for excellent early-career scientists (up to 3 years after graduation) at Helmholtz Zentrum München - German Research Center for Environmental Health.

30 Jan 2014

Scientists receive new awards from CIRM to advance revolutionary stem cell science in medicine

Scientists from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have received new awards from the California Institute of Regenerative Medicine (CIRM), the state stem cell research agency, that will forward revolutionary stem cell science in medicine.

30 Jan 2014

TCGA Research Network identify new potential therapeutic targets for major form of bladder cancer

Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified new potential therapeutic targets for a major form of bladder cancer, including important genes and pathways that are disrupted in the disease.

30 Jan 2014

Research News and Research

NeoGenomics validates and launches series of NeoTYPE cancer profiling tests

First Edition: January 30, 2014

Not all children, young adults treated achieve long-term relief from symptoms of anxiety

Alexion Pharmaceuticals reports full year 2013 GAAP and non-GAAP financial results

Thermo Fisher Scientific fourth quarter revenue increases 6% to $3.47 billion

Neuroscientist, researchers receive Vilcek Prize in Biomedical Science

American Cancer Society, SU2C partner to fight against cancer

New molecule could help lower diabetic patients' risk of developing dementia or Alzheimer's

Geranium plant extracts prevent HIV-1 from invading human cells

UCLH selects Nexthink's V5 modular platform to improve IT infrastructure

CTI announces initiation of pacritinib Phase 2 trial in AML patients with FLT3 mutations

Heart transplantation continues to be "gold standard" treatment for end-stage heart failure

Researchers engineer skin cells for first time containing blood and lymphatic capillaries

New pre-clinical data shows potential protective effects of GFT505 in different types of cancer

Singapore to become a major hub in Asia for food and nutrition research

Researcher to study how to address shortage of mental health services in Vietnam

Findings could improve clinical management of patients with breast tissue abnormalities

Postdoctoral Fellowship Program for excellent early-career scientists at Helmholtz Zentrum München

Scientists receive new awards from CIRM to advance revolutionary stem cell science in medicine

TCGA Research Network identify new potential therapeutic targets for major form of bladder cancer

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery